Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Asociación para Evitar la Ceguera en México

Status and phase: Terminated; Phase 4

Conditions: Macular Edema

Treatments: Drug: bevacizumab

Study type: Interventional

Funder types: Other

Identifiers

NCT00804206

APEC-040

Details and patient eligibility

About

Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.

Enrollment: 15 patients

Sex: All

Ages: 40 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with proliferative diabetic retinopathy
• patients with macular edema

Exclusion criteria

• patients with previous treatments
• patients with ocular surgeries

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 2 patient groups

Group A

Experimental group

Description:

Bevacizumab before panretinal photocoagulation.

Treatment:

Drug: bevacizumab

Drug: bevacizumab

Group B

Experimental group

Description:

Bevacizumab after panretinal photocoagulation

Treatment:

Drug: bevacizumab

Drug: bevacizumab